Exco InTouch

By Jonah Comstock September 20, 2016
Apple has hired Dr. Mike Evans, a Toronto doctor who boasts 70,000 followers on his medical-themed YouTube channel. Evans was formerly a staff physician at St. Michael's Hospital in Toronto. As CBC reported, Evans is a mobile health enthusiast who has talked on his YouTube show about a future in which he might precribe an Apple Watch app for high blood pressure. Apple doesn't typically comment on...
By Jonah Comstock June 20, 2016
Exco InTouch has launched a new app that creates a disease-specific social network for people with chronic urticaria, or hives. The app, called Target My Hives, was developed with funding and support from Novartis. The app, available on Android and Apple devices, was just formally announced by the companies, but it currently has 2,000 patients registered from 61 countries. It launched in May....
By Jonah Comstock December 11, 2014
Exco InTouch, the clinical trial technology vendor best known for its large-scale COPD program with AstraZeneca and the NHS trusts in England, has raised $5 million (3.2 million pounds). The round was led by Albion Ventures, according to British news site HealthInvestor. Scottish Equity Partners, Exco's largest shareholder, also contributed to the round. The Nottingham, England-based company...
By Aditi Pai June 17, 2014
A little over a year after completing a pilot study, pharmaceutical company AstraZeneca and Exco InTouch have launched a mobile-enabled program in the UK to help patients manage their chronic obstructive pulmonary disease (COPD), called Me&MyCOPD. The program has three components -- a portal in which patients can connect with providers, a server on which information is saved and messages are...
By Brian Dolan December 17, 2013
At the mHealth Summit outside of Washington, D.C. last week, Mike Shilling, director of business development at Exco InTouch, shared three examples of mobile-enabled clinical trials that recently finished up or are still underway. The trials each leveraged mobiles in different ways and helped highlight a few of the strategies for deploying them in support of a trial as well as the various...
By Jonah Comstock November 1, 2013
Clinical Ink, a pharma-focused mobile clinical trial data collection company, has raised $4.3 million. FCA Venture partners led the round, with additional funding from 10 undisclosed angel investors. Clinical Ink makes SureSource, a windows-based tablet software for healthcare providers to collect clinical trial data electronically at the point of care. They use Windows tablets because stylus...
By Aditi Pai September 19, 2013
Over the span of two days last week, Voalte, Audax Health and Google made mobile health hires. Over the span of a month, there have been seven total hiring announcements. While Voalte's new hire has a background in health, some, like Audax's addition of Zynga Chief Operating Officer (COO) David Ko was brought on to grow the company in a new way. MobiHealthNews has compiled a list of all the...
By Jonah Comstock March 1, 2013
A screenshot from Exco's clinical trial software. One of our predictions at the start of the year was that 2013 would be a year for pharma to make big moves in mobile health. European pharmaceutical company AstraZeneca has begun that process, announcing a pilot, in partnership with Exco InTouch, to address chronic obstructive pulmonary disease (COPD) in the UK using mobile and online tools....
By Jonah Comstock November 20, 2012
The now-defunct Healogica app. Clinical trials are a clear area where mobile engagement and big data have serious potential, but it's still a largely untapped use case. There have been a lot of stories recently about the opportunities in that space, but also on the challenges companies have encountered in implementing them. At least one abandoned study and one failed company can attest to those...
By Brian Dolan July 9, 2012
At the DIA Annual Meeting in Philadelphia last month, Vodafone and Exco InTouch announced a deal that sees Vodafone launching a new mobile-enabled clinical trial offering that leverages Exco's patient reported outcomes software for mobile phones. Exco made headlines last year when it inked a deal with pharmaceutical company Pfizer to determine how effective mobile-enabled clinical trials could be...

Editor's Pick